trending Market Intelligence /marketintelligence/en/news-insights/trending/vIEfI6KIScn3PrLXXNwWXQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Rigel to raise $40M in common stock offering

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Rigel to raise $40M in common stock offering

Rigel Pharmaceuticals Inc. priced an offering of 20 million shares at $2 apiece.

The clinical-stage biotechnology company will raise approximately $40 million in gross proceeds to fund research and development activities, among other things.

Rigel also granted the offering's underwriters a 30-day option to purchase up to an additional 3 million shares.

The offering is expected to close by Feb. 3

Jefferies LLC, Piper Jaffray & Co. and BMO Capital Markets are acting as the joint book-running managers for the offering, while H.C. Wainwright & Co. LLC is acting as lead manager.